Leire Burgos Rodríguez

Leire Burgos Rodríguez is a dedicated Researcher at the Cancer Center of the Clínica Universidad de Navarra (CCUN), operating within the University of Navarra's clinical research ecosystem. Her work centers on translational immunology applications for hematological malignancies through the Inmunómica traslacional en neoplasias hematológicas research group.

Education Background:

• Doctorate from University of Navarra (2013) with thesis: Determination of anti-HLA antibodies by solid phase techniques (Luminex) and their correlation with other clinical parameters and in vitro biological effects on lymphocytes
• Thesis supervised by Dr. Alfonso Sánchez Ibarrola and Dr. Cristina Moreno Parado

Research Focus: Dr. Burgos Rodríguez specializes in the clinical interpretation of anti-HLA antibody profiles using Luminex technology, investigating their biological impact on lymphocytes and correlations with patient outcomes in hematological cancers. Her work bridges laboratory immunodiagnostics with clinical oncology applications, particularly in transplant-related immunity and hematological neoplasm pathogenesis. Current efforts focus on developing antibody-based biomarkers for treatment response prediction in blood cancers.

Awards and Recognition: No specific scientific awards were documented in the source material.

Professional Context: As a core member of CCUN's translational immunomics team, she operates within Spain's premier cancer research infrastructure. While grant details remain unspecified, her position within the university clinic indicates institutional funding for hematological malignancy research. Her work supports clinical decision-making through advanced immunological profiling, with future directions likely targeting personalized immunotherapy approaches for hematological cancer patients.